Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents

Laboratory Investigation

Volumn 94, Issue 12, 2014, Pages 1406-1418

  Kennedy, Lindsey L ^a   Hargrove, Laura A ^b   Graf, Allyson B ^a   Francis, Taylor C ^c   Hodges, Kyle M ^b   Nguyen, Quy P ^a   Ueno, Yoshi ^d   Greene, John F ^b   Meng, Fanyin ^a,b,c   Huynh, Victoria D ^c   Francis, Heather L ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMASE; CROMOGLYCATE DISODIUM; HISTAMINE; HISTIDINE DECARBOXYLASE; TOLONIUM CHLORIDE; TRYPTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHOLESTASIS; CONTROLLED STUDY; ENZYME RELEASE; GENE EXPRESSION; HISTAMINE RELEASE; HYPERPLASIA; MALE; MAST CELL; MAST CELL DEGRANULATION; MTT ASSAY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; DISEASE MODEL; DRUG EFFECTS; FISCHER 344 RAT; INTRAHEPATIC BILE DUCT; METABOLISM; PATHOLOGY;

ANIMALS; BILE DUCTS, INTRAHEPATIC; CELL PROLIFERATION; CHOLESTASIS; CROMOLYN SODIUM; DISEASE MODELS, ANIMAL; HISTAMINE RELEASE; MALE; MAST CELLS; RATS; RATS, INBRED F344;

EID: 84922482143     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.129     Document Type: Article

References (62)

1. Park SM. The crucial role of cholangiocytes in cholangiopathies. Gut liver 2012;6:295-304.
2. Alpini G, Glaser S, Alvaro D, et al. Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats. Gastroenterology 2002;123:1226-1237.
3. Alpini G, Roberts S, Kuntz SM, et al. Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology 1996;110:1636-1643.
4. Alpini G, Ulrich C, Roberts S, et al. Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol 1997;272(2 Pt 1):G289-G297.
5. Alvaro D, Mancino MG, Glaser S, et al. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 2007;132:415-431.
6. LeSage G, Glaser S, Alpini G. Regulation of cholangiocyte proliferation. Liver 2001;21:73-80.
7. Meng F, Onori P, Hargrove L, et al. Regulation of the histamine/VEGF axis by miR-125b during cholestatic liver injury in mice. Am J Pathol 2014;184:662-673.
8. Ishizaka T, Mitsui H, Yanagida M, et al. Development of human mast cells from their progenitors. Curr Opin Immunol 1993;5:937-943.
9. Galli SJ, Tsai M, Wershil BK. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 1993;142:965-974.
10. Shiohara M, Koike K. Regulation of mast cell development. Chem Immunol Allergy 2005;87:1-21.
11. Jeziorska M, McCollum C, Woolley DE. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J Pathol 1997;182:115-122.
12. Patella V, Marino I, Lamparter B, et al. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J Immunol 1995;154:2855-2865.
13. Sperr WR, Bankl HC, Mundigler G, et al. The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. Blood 1994;84:3876-3884.
14. Bischoff SC. Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 2009;31:185-205.
15. Traver E, Torres R, de Mora F, et al. Mucosal mast cells mediate motor response induced by chronic oral exposure to ovalbumin in the rat gastrointestinal tract. Neurogastroenterol Motil 2010;22:e34-e43.
16. Chan A, Cooley MA, Collins AM. Mast cells in the rat liver are phenotypically heterogeneous and exhibit features of immaturity. Immunol Cell Biol 2001;79:35-40.
17. Irani AA, Schechter NM, Craig SS, et al. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986;83:4464-4468.
18. Koda W, Harada K, Tsuneyama K, et al. Evidence of the participation of peribiliary mast cells in regulation of the peribiliary vascular plexus along the intrahepatic biliary tree. Lab Invest 2000;80: 1007-1017.
19. Matsunaga Y, Terada T. Mast cell subpopulations in chronic inflammatory hepatobiliary diseases. Liver 2000;20:152-156.
20. Nakamura A, Yamazaki K, Suzuki K, et al. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis. Am J Gastroenterol 1997;92:2245-2249.
21. Stoyanova II. Relevance of mast cells and hepatic lobule innervation to liver injury. Rom J Gastroenterol 2004;13:203-209.
22. Herzig DJ, Kusner EJ. Effect of cromolyn sodium and deuterium oxide on anaphylactic histamine release from rat peritoneal mast cells in vitro. J Pharmacol Exp Ther 1975;194:457-462.
23. Murphy S, Kelly HW. Cromolyn sodium: a review of mechanisms and clinical use in asthma. Drug Intell Clin Pharm 1987;21(1 Pt 1):22-35.
24. Janssen LJ, Wattie J, Betti PA. Effects of cromolyn and nedocromil on ion currents in canine tracheal smooth muscle. Eur Respir J 1998;12:50-56.
25. Francis H, Franchitto A, Ueno Y, et al. H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMPdependent PKA/ERK1/2/ELK-1 pathway. Lab Invest 2007;87:473-487.
26. Marzioni M, Glaser S, Francis H, et al. Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology 2005;128:121-137.
27. Brower GL, Chancey AL, Thanigaraj S, et al. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am J Physiol Heart Circ Physiol 2002;283: H518-H525.
28. Francis HL, Demorrow S, Franchitto A, et al. Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2 and cAMP-dependent signaling mechanisms. Lab Invest 2012;92:282-294.
29. Rutenburg AM, Kim H, Fischbein JW, et al. Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity. J Histochem Cytochem 1969;17:517-526.
30. Albamonte MI, Albamonte MS, Stella I, et al. The infant and pubertal human ovary: Balbianis body-associated VASA expression, immunohistochemical detection of apoptosis-related BCL2 and BAX proteins, and DNA fragmentation. Hum Reprod 2013;28: 698-706.
31. DeMorrow S, Francis H, Gaudio E, et al. Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation. Am J Physiol Gastrointest Liver Physiol 2008;294:G506-G519.
32. Francis H, Demorrow S, Venter J, et al. Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma. Gut 2012;61:753-764.
33. Xue JL, Cheng XW. Using host 28S ribosomal RNA as a housekeeping gene for quantitative real-time reverse transcription-PCR (qRT-PCR) in virus-infected animal cells. Curr Protoc Microbiol 2010) Chapter 1:Unit1D.2.
34. Glaser S, Meng F, Han Y, et al. Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice. Gastroenterology 2014;146:1795-808 e12.
35. Beaven MA. Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol 2009;39:11-25.
36. Islam MA, Sumon SM, Rahman MW, et al. Comparison of creatinine clearance estimates with routine measured creatinine clearance in hospitalized chronic kidney disease patients. Mymensingh Med J 2014;23:213-220.
37. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol 1994;55:1-96.
38. Ueno Y, Alpini G, Yahagi K, et al. Evaluation of differential gene expression by microarray analysis in small and large cholangiocytes isolated from normal mice. Liver Int 2003;23:449-459.
39. Francis H, Glaser S, Demorrow S, et al. Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. Am J Physiol Cell Physiol 2008;295:C499-C513.
40. Glaser S, Wang M, Ueno Y, et al. Differential transcriptional characteristics of small and large biliary epithelial cells derived from small and large bile ducts. Am J Physiol Gastrointest Liver Physiol 2010;299:G769-G777.
41. Francis H, Glaser S, Ueno Y, et al. cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J Hepatol 2004;41:528-537.
42. Minagawa N, Nagata J, Shibao K, et al. Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile. Gastroenterology 2007;133:1592-1602.
43. Rosenthaler J, Guirard BM, Chang GW, et al. Purification and properties of histidine decarboxylase from Lactobacillus 30a. Proc Natl Acad Sci USA 1965;54:152-158.
44. Gaudio E, Barbaro B, Alvaro D, et al. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats. Am J Physiol Gastrointest Liver Physiol 2006;291:G307-G317.
45. Gaudio E, Barbaro B, Alvaro D, et al. Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. Gastroenterology 2006;130:1270-1282.
46. Kim CE, Lim SK, Kim JS. In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer. J Control Release 2012;157:190-195.
47. Melillo RM, Guarino V, Avilla E, et al. Mast cells have a protumorigenic role in human thyroid cancer. Oncogene 2010;29:6203-6215.
48. Akiyoshi H, Terada T. Mast cell, myofibroblast and nerve terminal complexes in carbon tetrachloride-induced cirrhotic rat livers. J Hepatol 1998;29:112-119.
49. Bardadin KA, Scheuer PJ. Mast cells in acute hepatitis. J Pathol 1986;149:315-325.
50. Farrell DJ, Hines JE, Walls AF, et al. Intrahepatic mast cells in chronic liver diseases. Hepatol 1995;22(4 Pt 1):1175-1181.
51. Rao KN, Brown MA. Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann NY Acad Sci 2008;1143:83-104.
52. Yamashiro M, Kouda W, Kono N, et al. Distribution of intrahepatic mast cells in various hepatobiliary disorders. An immunohistochemical study. Virchows Arch 1998;433:471-479.
53. Gittlen SD, Schulman ES, Maddrey WC. Raised histamine concentrations in chronic cholestatic liver disease. Gut 1990;31:96-99.
54. Nemmar A, Hoet PH, Vermylen J, et al. Pharmacological stabilization of mast cells abrogates late thrombotic events induced by diesel exhaust particles in hamsters. Circulation 2004;110:1670-1677.
55. Liu DZ, Chen ZG, Ge M, et al. Effects of cromolyn sodium on intestinal ischemia-reperfusion injury by inhibiting PAR-2 expression in rats. Zhonghua Yi Xue Za Zhi 2012;92:2597-2600.
56. Kim HH, Park SB, Lee S, et al. Inhibitory effect of putranjivain A on allergic inflammation through suppression of mast cell activation. Toxicol Appl Pharmacol 2014;274:455-461.
57. Volcheck GW, OConnell EJ. Anti-inflammatory drugs for controlling asthma. Postgrad Med 1998;104:127-136, 139.
58. Bolier R, Oude Elferink RP, Beuers U. Advances in pathogenesis and treatment of pruritus. Clin Liver Dis 2013;17:319-329.
59. Vessal G, Sagheb MM, Shilian S, et al. Effect of oral cromolyn sodium on CKD-associated pruritus and serum tryptase level: a double-blind placebo-controlled study. Nephrol Dial Transplant 2010;25:1541-1547.
60. Quist RG, Ton-Nu HT, Lillienau J, et al. Activation of mast cells by bile acids. Gastroenterology 1991;101:446-456.
61. Bunchorntavakul C, Reddy KR. Pruritus in chronic cholestatic liver disease. Clin Liver Dis 2012;16:331-346.
62. Schaefer B, Schaefer F, Wittmer D, et al. Molecular Adsorbents Recirculating System dialysis in children with cholestatic pruritus. Pediatr Nephrol 2012;27:829-834.